Long-term safety of crisaborole topical ointment, 2%, in atopic dermatitis

被引：1

作者：

Eichenfield, L. ^{[1
,2
]}

Call, R. S. ^{[9
]}

Forsha, D. ^{[3
]}

Fowler, J. ^{[4
]}

Hebert, A. A. ^{[5
]}

Spellman, M. ^{[6
]}

Gold, L. F. Stein ^{[7
]}

Van Syoc, M. ^{[6
]}

Zane, L. T. ^{[6
]}

Tschen, E. H. ^{[8
]}

机构：

[1] Rady Childrens Hosp, San Diego, CA USA

[2] Univ Calif San Diego, La Jolla, CA 92093 USA

[3] South Valley Dermatol, W Jordan, UT USA

[4] Dermatol Specialists Res LLC, Louisville, KY USA

[5] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA

[6] Anacor Pharmaceut Inc, Palo Alto, CA USA

[7] Henry Ford Hlth Syst, Detroit, MI USA

[8] Acad Dermatol Associates, Albuquerque, NM USA

[9] Clin Res Partners LLC, Henrico, VA USA

来源：

JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2016年 / 136卷 / 05期

关键词：

D O I：

10.1016/j.jid.2016.02.310

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

280

引用

页码：S49 / S49

页数：1

共 50 条

[1] LONG-TERM SAFETY OF CRISABOROLE TOPICAL OINTMENT, 2%, IN ATOPIC DERMATITIS
Eichenfield, L.
Call, R.
Forsha, D.
Fowler, J.
Hebert, A.
Spellman, M.
Gold, L. Stein
Van Syoc, M.
Zane, L.
Tschen, E.
[J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S21 - S21
[2] Long-term safety of Crisaborole Topical Ointment, 2%, in children and adults with mild to -moderate atopic dermatitis
Zane, Lee Thomas
Eichenfield, Lawrence F.
Call, Robert S.
Forsha, Douglass W.
Fowler, Joseph F.
Hebert, Adelaide A.
Spellman, Mary
Gold, Linda F. Stein
Van Syoc, Merrie
Tschen, Eduardo H.
[J]. JOURNAL OF IMMUNOLOGY, 2016, 196
[3] Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis
Eichenfield, Lawrence F.
Call, Robert S.
Forsha, Douglass W.
Fowler, Joseph, Jr.
Hebert, Adelaide A.
Spellman, Mary
Gold, Linda F. Stein
Van Syoc, Merrie
Zane, Lee T.
Tschen, Eduardo
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (04) : 641 - +
[4] Efficacy and safety trends with continuous long-term use of 2% crisaborole ointment in patients with mild to moderate atopic dermatitis
Lebwohl, Mark G.
Hebert, Adelaide A.
Takiya, Liza
Miller, Lauren E.
Werth, John L.
Zang, Chuanbo
Sanders, Paul
Geng, Bob
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB21 - AB21
[5] Long-term safety of tacrolimus ointment in atopic dermatitis
Remitz, Anita
Reitamo, Sakari
[J]. EXPERT OPINION ON DRUG SAFETY, 2009, 8 (04) : 501 - 506
[6] Efficacy and safety trends with continuous long-term use of crisaborole ointment 2% in patients with mild-to-moderate atopic dermatitis
Lebwohl, M. G.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (04) : E100 - E101
[7] 2% Crisaborole topical ointment for the treatment of mild-to-moderate atopic dermatitis
Cheape, Alice C.
Murrell, Dedee F.
[J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (05) : 415 - 423
[8] Long-term safety of crisaborole ointment, 2%, across racial and ethnic groups
Callender, Valerie
Alexis, Andrew
Gold, Linda Stein
Lebwohl, Mark
Desai, Seemal
Paller, Amy
Tan, Huaming
Vranc, Ivana
Ports, William
Zielinski, Michael
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB182 - AB182
[9] Long-term safety and efficacy of delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with atopic dermatitis
Nakagawa, Hidemi
Nemoto, Osamu
Igarashi, Atsuyuki
Saeki, Hidehisa
Murata, Ryusei
Kaino, Hironobu
Nagata, Takeshi
[J]. JOURNAL OF DERMATOLOGY, 2020, 47 (02): : 114 - 120
[10] Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children
Remitz, Anita
Harper, John
Rustin, Malcolm
Goldschmidt, Wouter F. M.
Palatsi, Riitta
van der Valk, Pieter G. M.
Sharpe, Graham
Smith, Catherine H.
Dobozy, Attila
Turjanmaa, Kristiina
[J]. ACTA DERMATO-VENEREOLOGICA, 2007, 87 (01) : 54 - 61

← 1 2 3 4 5 →